Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 152Breast Neoplasms 40Prostatic Neoplasms 31Insulin Resistance 30Obesity 23Neoplasms 15Endometrial Neoplasms 15Pancreatic Neoplasms 14Infertility 14Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 12Anovulation 10Lung Neoplasms 9Neoplasm Metastasis 8Hyperandrogenism 8Glioblastoma 8Diabetes Mellitus 8Squamous Cell Carcinoma of Head and Neck 7Metabolic Syndrome 7Melanoma 7Rectal Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Head and Neck Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Weight Loss 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4

Interventions

bicalutamide 2Mifepristone 2Metformin 2Corlux 2drospirenone and ethinyl estradiol combination 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Time 1Magnesium 1Insulin 1Hematologic Tests 1Folic Acid 1Flutamide 1Ethinyl Estradiol 1Cyproterone acetate, ethinyl estradiol drug combination 1Cyproterone Acetate 1Carnitine 1Cardiovascular Physiological Phenomena 1Body Mass Index 1Body Composition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hirsutism × Metformin × Clear all
NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Columbia University

Phase 4 Terminated
3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT00428311 2007-01-31

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Hospital Universitario Ramon y Cajal

Phase 4 Completed
50 enrolled

Hirsutism, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡